External Validation of the UK‐BCIS CHIP Score to Predict 1‐Year Outcomes in Patients Undergoing IVL‐Assisted PCI: Insights From the International BENELUX‐IVL Registry
Catheterization and Cardiovascular Interventions · 09.11.2026
DOI: 10.1002/ccd.70992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 09.11.2026. Verfasst von Akshay A S Phagu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The United Kingdom–British Cardiovascular Intervention Society complex high‐risk indicated percutaneous coronary intervention (UK‐BCIS CHIP) score was developed to identify patient‐ and procedural factors to predict short‐term adverse outcomes in patients undergoing high risk percutaneous coronary intervention (PCI). The performance of the UK‐BCIS CHIP score in a patient population treated with intravascular lithotripsy (IVL) for severe coronary calcification remains unknown.
Aims
To evaluate the prognostic performance of the UK‐BCIS CHIP score in patients undergoing IVL‐assisted PCI for severe coronary calcification, and to assess procedural and 1‐year clinical outcomes across CHIP score categories.
Methods
This international, multicenter, prospective study included consecutive patients undergoing IVL‐assisted PCI between May 2019 and December 2025 from the BENELUX‐IVL registry. Patients were stratified according to UK‐BCIS CHIP score categories (0, 1–2, 3–4, and ≥ 5). The primary endpoint was 1‐year major adverse cardiac events (MACE), defined as a composite of cardiovascular death, non‐fatal myocardial infarction, or clinically driven target vessel revascularization. Secondary endpoints included all‐cause mortality, procedural outcomes, and periprocedural complications. Discrimination of the UK‐BCIS CHIP score was assessed using the AUC for in‐hospital events and the Harrell's C‐index for 1‐year outcomes.
Results
A total of 911 patients were included. Higher UK‐BCIS CHIP scores were associated with increased clinical comorbidity, lesion complexity, and procedural intensity. Procedural, device, and technical success rates were comparable across UK‐BCIS CHIP score categories (85.1%, 94.4%, and 85.7% overall; p = 0.850, p = 0.813, and p = 0.781, respectively). Complications requiring intervention occurred in 5.5% of patients and did not differ significantly across CHIP score categories ( p = 0.347). The 1‐year cumulative incidence of MACE, accounting for all‐cause death as a competing risk, did not differ significantly across UK‐BCIS CHIP score categories (Gray's test p = 0.53).
Conclusion
In IVL‐assisted PCI, the UK‐BCIS CHIP score effectively identifies patients with increased clinical and procedural complexity but shows limited discrimination for mid‐term ischemic outcomes. IVL‐assisted PCI is safe and effective across the full spectrum of CHIP risk, while long‐term prognosis appears primarily driven by underlying comorbidity burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Cardiology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.
- Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Cardiology, Frisius Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands.
- Department of Cardiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
ORCID-Profile: Akshay A S Phagu, Martijn J H van Oort, Brian O Bingen, Valeria Paradies, Gianluca Mincione, Tessel N Vossenberg, Alessandro Mandurino-Mirizzi, Marios Sagris, Maria Mouratidou, Ioannis Karalis, Frank van der Kley, J Wouter Jukema, Ibtihal Al Amri, Jose M Montero-Cabezas
Zitieren
APA
Phagu, A. A. S., Forouzanfar, J. P., van Oort, M. J. H., Oliveri, F., Bingen, B. O., Paradies, V., Mincione, G., Claessen, B. E. P. M., Dimitriu-Leen, A. C., Vossenberg, T. N., Kefer, J., Mandurino-Mirizzi, A., Sagris, M., Mouratidou, M., Karalis, I., van der Kley, F., Wouter Jukema, J., Amri, I. A., & Montero-Cabezas, J. M. (2026). External Validation of the UK‐BCIS CHIP Score to Predict 1‐Year Outcomes in Patients Undergoing IVL‐Assisted PCI: Insights From the International BENELUX‐IVL Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70992
Vancouver
Phagu AAS, Forouzanfar JP, van Oort MJH, Oliveri F, Bingen BO, Paradies V, et al. External Validation of the UK‐BCIS CHIP Score to Predict 1‐Year Outcomes in Patients Undergoing IVL‐Assisted PCI: Insights From the International BENELUX‐IVL Registry. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70992
BibTeX
@article{Phagu2026,
author = {Phagu, Akshay A S and Forouzanfar, Jessica P and van Oort, Martijn J H and Oliveri, Federico and Bingen, Brian O and Paradies, Valeria and Mincione, Gianluca and Claessen, Bimmer E P M and Dimitriu-Leen, Aukelien C and Vossenberg, Tessel N and Kefer, Joelle and Mandurino-Mirizzi, Alessandro and Sagris, Marios and Mouratidou, Maria and Karalis, Ioannis and van der Kley, Frank and Wouter Jukema, J and Amri, Ibtihal Al and Montero-Cabezas, Jose M},
title = {External Validation of the UK‐BCIS CHIP Score to Predict 1‐Year Outcomes in Patients Undergoing IVL‐Assisted PCI: Insights From the International BENELUX‐IVL Registry},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70992}
}
EUVIMED